About Cellply
Cellply is a company based in Bologna (Italy) founded in 2013 by Roberto Guerrieri and Massimo Bocchi.. Cellply has raised $8.05 million across 9 funding rounds from investors including European Commission, European Union and Liftt. Cellply offers products and services including VivaCyte platform. Cellply operates in a competitive market with competitors including Kiyatec, Lucid Scientific, DiscoverX, CytoTronics and Saguaro, among others.
- Headquarter Bologna, Italy
- Founders Roberto Guerrieri, Massimo Bocchi
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Cellply S.R.L.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$8.05 M (USD)
in 9 rounds
-
Latest Funding Round
$3.79 M (USD), Series A
Sep 29, 2023
-
Investors
European Commission
& 11 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Cellply
Cellply offers a comprehensive portfolio of products and services, including VivaCyte platform. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Enables automated characterization of immune cells for cell therapy research
Unlock access to complete
Funding Insights of Cellply
Cellply has successfully raised a total of $8.05M across 9 strategic funding rounds. The most recent funding activity was a Series A round of $3.79 million completed in September 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 9
- Last Round Series A — $3.8M
-
First Round
First Round
(20 Mar 2014)
- Investors Count 12
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2023 | Amount | Series A - Cellply | Valuation | LIFTT | |
| Sep, 2022 | Amount | Grant - Cellply | Valuation |
investors |
|
| Dec, 2021 | Amount | Seed - Cellply | Valuation | Rearden , Metaventures |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Cellply
Cellply has secured backing from 12 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include European Commission, European Union and Liftt. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm focused on multiple sectors
|
Founded Year | Domain | Location | |
|
Potato farming, grain marketing, and equipment services associated with Rearden.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Cellply
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Cellply
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Cellply Comparisons
Competitors of Cellply
Cellply operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Kiyatec, Lucid Scientific, DiscoverX, CytoTronics and Saguaro, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Kiyatec is focused on revolutionizing cancer care through predictive platforms.
|
|
| domain | founded_year | HQ Location |
Real-time cell analyzers are developed for oxygen consumption monitoring.
|
|
| domain | founded_year | HQ Location |
Develops cell-based assays and provides services for drug discovery and development.
|
|
| domain | founded_year | HQ Location |
Cell-based assays for drug discovery are developed via CMOS platform.
|
|
| domain | founded_year | HQ Location |
3D cell culture products are developed for drug discovery applications.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Cellply
Frequently Asked Questions about Cellply
When was Cellply founded?
Cellply was founded in 2013 and raised its 1st funding round 1 year after it was founded.
Where is Cellply located?
Cellply is headquartered in Bologna, Italy. It is registered at Bologna, Emilia-romagna, Italy.
Who is the current CEO of Cellply?
Emiliano Spagnolo is the current CEO of Cellply.
Is Cellply a funded company?
Cellply is a funded company, having raised a total of $8.05M across 9 funding rounds to date. The company's 1st funding round was a Seed of $2.26M, raised on Mar 20, 2014.
What does Cellply do?
Cellply was founded in 2013 in Bologna, Italy, within the biotechnology sector focused on in-vitro diagnostics. Products for cancer detection are developed, including the ONCOSMART system, which assesses anticancer drug responses in live cells from individual patients. Prognostic tests evaluating immune profiles in hospitalized COVID-19 patients are also provided. Operations center on personalized oncology testing and infectious disease monitoring.
Who are the top competitors of Cellply?
Cellply's top competitors include CytoTronics, Kiyatec and Remedy Plan.
What products or services does Cellply offer?
Cellply offers VivaCyte platform.
Who are Cellply's investors?
Cellply has 12 investors. Key investors include European Commission, European Union, Liftt, Meta Group, and Recomec.com.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.